Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P1.03-028 - A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Untreated Stage IV Squamous Cell Lung Cancers
09:30 - 09:30 | Presenter: Paul K. Paik | Author(s): A. Srikakulum, L. Ahn, A. Plodkowski, K. Ng, D. McFarland, J. Fiore, A. Iqbal, J. Eng, Mark G Kris, Charles M Rudin
- Abstract
Loading...
-
+
OA 03 - Mediastinal and Esophageal Tumor: Insight and New Treatment
- 11:00 - 12:30
- 10/16/2017
- Location: Room 311 + 312
- Type: Oral
- Track: Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- Moderators:M. Chida, Jhingook Kim
-
+
OA 03.03 - Phase II Trial of Cetuximab and Chemotherapy Followed by Surgical Resection for Locally Advanced Thymoma
11:20 - 11:30 | Presenter: James Huang | Author(s): D.J. Raz, M. Cristea, Kay See Tan, K. Deonaraine, A. Starr, William D Travis, M.S. Ginsberg, D. Jones, Valerie W Rusch, Mark G Kris, Gregory J Riely
- Abstract
Loading...
-
+
OA 05 - Next Generation TKI
- 15:45 - 17:30
- 10/16/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:James Chih-Hsin Yang, Fiona Blackhall
-
+
OA 05.04 - Discussant - OA 05.01, OA 05.02, OA 05.03
16:15 - 16:30 | Presenter: Mark G Kris
- Abstract
No abstract available for this presentation
-
+
P3.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P3.03-007 - LCMC2: Expanded Profiling of Lung Adenocarcinomas Identifies ROS1 and RET Rearrangements and TP53 Mutations as a Negative Prognostic Factor
09:30 - 09:30 | Presenter: Mark G Kris | Author(s): D.L. Aisner, L.M. Sholl, L.D. Berry, M. Rossi, H. Chen, J. Fujimoto, Andre L. Moreira, Suresh S Ramalingam, L.C. Villaruz, G. Otterson, E. Haura, K. Politi, B. Glisson, J. Cetnar, Edward Brian Garon, Joan Schiller, S.N. Waqar, Lecia V Sequist, Julie R Brahmer, Yu Shyr, K. Kugler, Ignacio I. Wistuba, B.E. Johnson, J. Minna, Paul A. Bunn, Jr., D.J. Kwiatkowski
- Abstract
Loading...
-
+
OA 14 - New Paradigms in Clinical Trials
- 11:00 - 12:30
- 10/18/2017
- Location: Room 311 + 312
- Type: Oral
- Track: Clinical Design, Statistics and Clinical Trials
- Moderators:Alex Adjei, Eun Kyung Cho
-
+
OA 14.05 - Phase 2 Basket Trial of Ado-Trastuzumab Emtansine in Patients with HER2 Mutant or Amplified Lung Cancers
11:45 - 11:55 | Presenter: Bob T. Li | Author(s): R. Shen, D. Buonocore, Z.T. Olah, A. Ni, M.S. Ginsberg, G. Ulaner, W. Weber, Dana W.Y. Tsui, M. Offin, H.H. Won, Marc Ladanyi, Gregory J Riely, D.B. Solit, D.M. Hyman, Charles M Rudin, M.F. Berger, J. Baselga, M. Scaltriti, Maria E Arcila, Mark G Kris
- Abstract
Loading...